# WellSpan-THRIVE Cancer QOL Study

> **NCT07433660** · — · RECRUITING · sponsor: **WellSpan Health** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative
- Cancer (Solid Tumors)
- Cancer (With or Without Metastasis)
- Cancer - Ovarian
- Cancer Abdomen
- Cancer (Advanced Stage)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07433660
- **Lead sponsor:** WellSpan Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2031-02
- **Final completion:** 2031-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433660, "WellSpan-THRIVE Cancer QOL Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07433660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*